-
肿瘤外泌体通过CD19诱导CAR-T初始激活但通过TGFβ信号传导损害CAR-T细胞功能
讲者:郝渊渊 -
派安普利单抗联合利妥昔单抗、甲氨蝶呤及阿糖胞苷(Pen-RMA)治疗初诊原发中枢神经系统淋巴瘤(PCNSL)的有效性及安全性的II期临床研究(NCT05347641)
讲者:申浩睿 -
PTGDS serves as a novel therapeutic target in peripheral T cell lymphoma via regulation of iron metabolism
讲者:胡顺凤 -
Integrating p53-associated Genes and Infiltrating Immune Cell Characterization as a Prognostic Biomarker in Multiple Myeloma
讲者:杜俊 -
嵌合抗原受体修饰造血干细胞治疗B细胞淋巴瘤的初步研究
讲者:王桃 -
CART细胞治疗的药代动力学研究
讲者:陈丽婷 -
Tislelizumab Augment the Efficacy of CD19/22 Dual-Targeted Chimeric Antigen Receptor T cells in Advanced Stage Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
讲者:张莹 -
老年AML
讲者:张苏江 -
m6A修饰的circTET2通过结合HNRNPC促进慢性淋巴细胞白血病脂肪酸氧化过程及疾病进展
讲者:伍紫娟 -
心脏PET/CT联合磁共振成像评估多发性骨髓瘤患者心血管损伤
讲者:蔺诗佳 -
Allo-HSCT联合CD7 CAR-T治疗复发难治T淋巴母细胞淋巴瘤
讲者:王祥民 -
499例淋巴瘤患者中发生中枢神经系统浸润的临床特征分析
讲者:刘洋